Silence Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
LONDON--(BUSINESS WIRE)--Nov 14, 2023--
Source: eagletribune.com
Page 20 - Program Updates News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Program Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Program Updates Today - Breaking & Trending Today
Travere Therapeutics Reports Third Quarter 2023 Financial Results
Received 430 new patient start forms for FILSPARI® in the third quarter of 2023; demand and payer coverage continued to grow Net product sales of FILSPARI...
Source: marketscreener.com
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
Updated data from azenosertib monotherapy study with longer follow up shows 37% ORR and mPFS of 6.5 months in heavily pretreated ovarian and uterine serous carcinoma patients Azenosertib programs on...
Source: marketscreener.com
Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
US FDA accepted NDA filing for ensifentrine for maintenance treatment of COPD PDUFA Target Action Date of June 26, 2024 Commercial launch preparations supported by strong balance sheet Conference...
Source: marketscreener.com
Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis - Nkarta (NASDAQ:NKTX)
New pipeline program builds on academic studies of durable, drug-free remissions in patients with autoimmune disease after CD19-targeted cell therapy NKX019, an allogeneic CAR NK cell therapy targeting CD19+ B
Source: benzinga.com